Eczema Clinical Trial - Assessment of the Effects on the Skin Microbiome

Clinical Trial Summary

This is a single-center, randomized, blinded, controlled trial assessing the effects on the skin microbiome in patients with eczema of amending a standard-of-care (SOC), over-the-counter (OTC) topical colloidal oatmeal formulation with a modified plant oil ("Activated Oil", AO)

See also
Status	Clinical Trial	Phase
Completed	`NCT01257061` - Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment	Phase 3
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Withdrawn	`NCT03089476` - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy	N/A
Recruiting	`NCT04818138` - BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort	N/A
Recruiting	`NCT05439577` - A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02075632` - Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream	Phase 2
Completed	`NCT00143819` - Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis	Phase 2
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Not yet recruiting	`NCT04520308` - An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis	Phase 4
Completed	`NCT04358224` - The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment	Phase 4
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT04023084` - Response of Children With Atopic Dermatitis (Eczema) to Eucrisa	Phase 4
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Completed	`NCT05583019` - Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)
Completed	`NCT03293030` - Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis	Phase 4
Completed	`NCT02002871` - Blue Light for Treating Eczema	N/A
Completed	`NCT01420705` - Bacille Calmette-Guérin (BCG) Vaccine and Atopy	N/A
Recruiting	`NCT01012453` - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema	N/A
Completed	`NCT00375713` - Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema	Phase 3

NCT number	NCT05413395
Study type	Interventional
Source	GlycosBio, Inc.
Contact	Daniel J Monticello, Ph.D.
Phone	(346) 772-0354
Email	dmonticello@glycosbio.com
Status	Recruiting
Phase	N/A
Start date	June 17, 2022
Completion date	March 1, 2024

Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms